Posted on April 20, 2011
NEWBURYPORT, MA – (April 20, 2011) – AgilePath Corporation, a leading IT
management and technology consulting firm, today announced its new location in
Concord, California to support business expansion in the Western Region of the United
States in support of current Commercial, Federal and State Government business
opportunities. AgilePath also announced the appointment of Mr. Kevin King as the
Director of West Coast Operations for AgilePath’s Federal and Commercial practice. Mr.
King’s appointment is instrumental to support of AgilePath’s West Coast growth strategy.
“AgilePath has emerged from the economic downturn in a position of strength, and we
are executing our next phase of growth,” stated AgilePath CEO Eric Marks.
“Establishing a West Coast presence is crucial to our expansion, as is tapping into the
technology talent base in Silicon Valley and the Bay Area. We are very pleased to bring
Kevin King onboard to support our growth objectives.”
“I’m very excited to be a part of such a well-established, respected firm that is
recognized for its exceptional thought leadership in the IT consulting industry.
I’m pleased with the opportunity to contribute to the success of AgilePath,
specifically in the areas of Enterprise Governance, SOA and Cloud computing,
and to help shape the future of technology leadership across many domains ,”
stated Mr. King.
In addition, AgilePath announced the promotion of Mr. Mark Ferrara to Director of DoD
Programs. Mr. Ferrarra will oversee major DoD programs and client relationships for the
U.S. Air Force, Army and Navy, as well as special programs as they arise.
“This promotion serves as recognition of Mark Ferrarra’s significant contributions to
AgilePath and our Clients,” stated Eric Marks, AgilePath CEO. “We are pleased to give
Mark new opportunities to grow professionally and personally with AgilePath in this
“I am thrilled to take on the responsibilities of this position and very much look forward
to new challenges that I will take on with great commitment,” stated Mr. Ferrara.